Cite

HARVARD Citation

    Kohli, A. et al. (2015). Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Lancet. 385 (9973), pp. 1107-1113. [Online]. 
  
Back to record